CellSolutions, a Greensboro-based company focused on cytology, the testing of tissue samples, has amended its recent filing with the U.S. Securities and Exchange Commission to increase its equity funding round increased to $900,000.

CellSoutions develops liquid-based preparation and evaluations systems for cytology applications. Pending FDA-PMA approval, its primary areas of focus will be women’s health, including cervical cancer screening, pre-cancer detection and evaluation of infectious disease.

It currently sells a range of cytology products, ranging from sample collection to preservation and slide preparation and advanced image analysis.

Previously on WRAL Techwire:

Greensboro-based CellSolutions raises $450,000 from 3 investors (+ video)